Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G A Hitman

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|May 17, 2011
Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetesE L Edghill, A Khamis, M N Weedon, et al.
Diabetologia|April 8, 2006
Common variations in the ALMS1 gene do not contribute to susceptibility to type 2 diabetes in a large white UK populationS Patel, J A L Minton, M N Weedon, et al.
Clinical and Experimental Immunology|June 29, 2019
Type 2 diabetes is associated with the accumulation of senescent T cellsE Y M Lau, E C Carroll, L A Callender, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
Diabetologia|February 1, 2007
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)M Raikou, A McGuire, H M Colhoun, et al.
Annals of Human Genetics|October 19, 2006
Epistasis between type 2 diabetes susceptibility Loci on chromosomes 1q21-25 and 10q23-26 in northern EuropeansS Wiltshire, J T Bell, C J Groves, et al.
The British Journal of Dermatology|February 26, 2009
Filaggrin mutations are associated with ichthyosis vulgaris in the Bangladeshi populationC Sinclair, E A O'Toole, D Paige, et al.
Atherosclerosis|June 24, 2003
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart diseaseS S Soedamah-Muthu, H M Colhoun, M J Thomason, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 13, 2006
Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samplesE Zeggini, J R C Parkinson, S Halford, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
Diabetic Medicine : a Journal of the British Diabetic Association|May 17, 2011
Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetesE L Edghill, A Khamis, M N Weedon, et al.
Diabetologia|April 8, 2006
Common variations in the ALMS1 gene do not contribute to susceptibility to type 2 diabetes in a large white UK populationS Patel, J A L Minton, M N Weedon, et al.
Clinical and Experimental Immunology|June 29, 2019
Type 2 diabetes is associated with the accumulation of senescent T cellsE Y M Lau, E C Carroll, L A Callender, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.
Diabetologia|February 1, 2007
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)M Raikou, A McGuire, H M Colhoun, et al.
Annals of Human Genetics|October 19, 2006
Epistasis between type 2 diabetes susceptibility Loci on chromosomes 1q21-25 and 10q23-26 in northern EuropeansS Wiltshire, J T Bell, C J Groves, et al.
The British Journal of Dermatology|February 26, 2009
Filaggrin mutations are associated with ichthyosis vulgaris in the Bangladeshi populationC Sinclair, E A O'Toole, D Paige, et al.
Atherosclerosis|June 24, 2003
The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart diseaseS S Soedamah-Muthu, H M Colhoun, M J Thomason, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 13, 2006
Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samplesE Zeggini, J R C Parkinson, S Halford, et al.
Pageof 18